Background: Breast cancer is a heterogeneous neoplasm. Distinct subtypes of breast cancer have been defined, suggesting the existence of molecular differences contributing to their clinical outcomes.
The goal of this study was to identify signalling molecules downstream of CXCR4 in breast cancer cells. For this purpose, we sorted CXCR4-positive and CXCR4-negative cells from MDA-MB-231 breast cance
本数据集为复旦大学附属肿瘤医院(FUSCC)HER2-low乳腺癌研究的最小数据集,对应2023年发表于《Nature Communications》的研究,包含中国HER2-low乳腺癌患者的分子特征与临床异质性相关数据,共1个文件。 论文“Molecular features and clinical implications of the heterogeneity in Chinese p
PurposesMost molecular-based published studies on breast cancer do not adequately represent the unique and diverse genetic admixture of the Latin American population. Searching for similarities and di